Cyngn Regains Nasdaq Compliance
MENLO PARK, Calif., March 13, 2025 /PRNewswire/ — Cyngn Inc. (Nasdaq: CYN) (or the “Company”) announced today that it has received a notice from... Read more.
Women’s Health Pioneer Tia Rolls Out Nabla’s AI Assistant To Enhance the Patient-Provider Relationship
Tia’s mission is to help women live healthier lives by driving the highest standard of care for women by integrating primary care with gynecology, mental health,... Read more.
EngFlow Acquires tipi.build, Brings Modern Build System Features to the C and C++ Community
The companies extend their previous collaboration on the CMake remote build execution service to deliver faster builds, next generation capabilities and improved... Read more.
ZINFI Releases New Complimentary Guidebook on the Future of Partner Ecosystems
New In-Depth Exploration of Partner Management Focuses on AI, Industry Specialization and Growth PLEASANTON, Calif., March 13, 2025 /PRNewswire/ — ZINFI... Read more.
Corero Network Security Accelerates AI Integration with Focus on Substance Over Hype
MARLBOROUGH, Mass., March 13, 2025 /PRNewswire/ — Corero Network Security (AIM: CNS) (OTCQX: DDOSF), the DDoS protection specialists, today announced the... Read more.
Bria Secures $40M in Series B to Drive Fair Gen AI Usage for Enterprises
The company will expand its state-of-the-art visual generative AI platform to bolster creation of scalable AI-driven visual products for enterprises without infringing... Read more.
Explore Cutting-Edge Advances in IT and Cybersecurity on Advancements with Ted Danson
Discover how ethical innovation is transforming the future of big data protection. JUPITER, Fla., March 13, 2025 /PRNewswire/ — Advancements with Ted Danson is... Read more.
Alithya to Showcase AI Innovation at AI Agent & Copilot Summit 2025
ALPHARETTA, Ga., March 13, 2025 /PRNewswire/ – Alithya Group inc. (TSX: ALYA) (“Alithya”) announces its sponsorship of the AI Agent & Copilot... Read more.
Third Arc Bio Announces First Patient Dosed in Phase 1 Clinical Trial of Lead T Cell Engager ARC101 to Treat CLDN6 Positive Cancers
— ARC101 is the company’s first bispecific antibody targeting Claudin 6 (CLDN6), optimized for best-in-class T cell engagement — First-in-human... Read more.
Interplay Learning Launches Interplay Achieve for Education and Workforce Development Organizations
Interplay Achieve includes simulation-based courses and learning pathways for in-demand careers in the construction and industrial trades. AUSTIN, Texas, March... Read more.